Disclosed herein are dermatological formulations comprising low-impurity TOFA prodrug 2-(2-ethoxy-2-oxoethyl)(methyl)amino-2-oxoethyl 5-(tetradecyloxy)furan-2-carboxylate represented by Formula (la) and pharmaceutical use thereof.
本文揭示了含有低杂质TOFA前药2-(2-乙氧基-2-氧代乙基)(甲基)
氨基-2-氧代乙基-5-(
十四烷氧基)
呋喃-2-
羧酸酯(
化学式为la)的皮肤科配方及其药用。